Hull D. Thomas's Insider Trades & SAST Disclosures
Hull D. Thomas's most recent trade in Kewaunee Scientific Corporation was a trade of 2,200 Common Stock done at an average price of $45.5 . Disclosure was reported to the exchange on March 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Hull D. Thomas.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 45.46 per share. | 21 Mar 2025 | 2,200 | 38,716 (1%) | 0% | 45.5 | 100,012 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 46.10 per share. | 21 Mar 2025 | 800 | 37,916 (1%) | 0% | 46.1 | 36,880 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 48.53 per share. | 21 Mar 2025 | 213 | 40,916 (1%) | 0% | 48.5 | 10,337 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 60.08 per share. | 10 Jan 2025 | 1,368 | 41,129 (1%) | 0% | 60.1 | 82,189 | Common Stock |
| Kewaunee Scientific Corpor... | D. Thomas Hull | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 63.01 per share. | 26 Dec 2024 | 2,000 | 42,497 (1%) | 0% | 63.0 | 126,020 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Dec 2024 | 1,000 | 44,497 (1%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2024 | 1,000 | 45,497 (1%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.00 per share. | 16 Jul 2024 | 7,877 | 46,497 (1%) | 0% | 52 | 409,604 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.62 per share. | 16 Jul 2024 | 6,000 | 54,374 (1%) | 0% | 23.6 | 141,720 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.64 per share. | 16 Jul 2024 | 6,000 | 48,374 (1%) | 0% | 16.6 | 99,840 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 6,000 | 0 | - | - | Option to Buy FY17 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 6,000 | 0 | - | - | Option to Buy | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 14,587 | 48,787 (1%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.86 per share. | 30 Jun 2024 | 6,413 | 42,374 (1%) | 0% | 44.9 | 287,687 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 5,357 | 5,357 | - | - | Restricted Stock Units FY23 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 5,097 | 0 | - | - | Restricted Stock Units FY22 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 4,133 | 37,194 | - | - | Restricted Stock Units FY24 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 19,806 | 19,806 | - | - | Restricted Stock Units FY25 | |
| Kewaunee Scientific Corpor... | Hull D. Thomas | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 22.80 per share. | 13 Dec 2023 | 6,000 | 34,200 (1%) | 0% | 22.8 | 136,800 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 10,453 | 44,160 (1%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 5,357 | 10,714 | - | - | Restricted Stock Units FY23 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 5,096 | 5,097 | - | - | Restricted Stock Units FY22 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.90 per share. | 30 Jun 2023 | 2,960 | 41,200 (1%) | 0% | 15.9 | 47,064 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 41,327 | 41,327 | - | - | Restricted Stock Units FY24 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2023 | 19,733 | 39,292 (1%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2023 | 16,382 | 0 | - | - | Restricted Stock Units FY21 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.47 per share. | 23 Jun 2023 | 5,585 | 33,707 (1%) | 0% | 16.5 | 91,985 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 15.23 per share. | 04 Apr 2023 | 991 | 19,559 (0%) | 0% | 15.2 | 15,093 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 21 Mar 2023 | 100 | 20,550 (0%) | 0% | 16 | 1,600 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 16.05 per share. | 14 Mar 2023 | 1,409 | 20,650 (0%) | 0% | 16.0 | 22,614 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 16.17 per share. | 05 Jan 2023 | 1,000 | 22,059 (0%) | 0% | 16.2 | 16,170 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 1,000 | 23,059 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 16,071 | 16,071 | - | - | Restricted Stock Units FY23 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | 29 Jun 2022 | 5,096 | 10,193 | - | - | Restricted Stock Units FY22 | ||
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2022 | 5,096 | 25,514 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.77 per share. | 29 Jun 2022 | 1,455 | 24,059 (0%) | 0% | 15.8 | 22,945 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2022 | 2,980 | 16,382 | - | - | Restricted Stock Units FY21 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2022 | 2,980 | 21,269 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.82 per share. | 23 Jun 2022 | 851 | 20,418 (0%) | 0% | 13.8 | 11,761 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2022 | 7,138 | 0 | - | - | Restricted Stock Units | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2022 | 7,138 | 20,327 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.99 per share. | 21 Jun 2022 | 2,038 | 18,289 (0%) | 0% | 14.0 | 28,512 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2021 | 2,749 | 13,981 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.75 per share. | 08 Jul 2021 | 792 | 13,189 (0%) | 0% | 13.8 | 10,890 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 303 | 0 | - | - | Restricted Stock Units | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 303 | 11,320 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.70 per share. | 28 Jun 2021 | 88 | 11,232 (0%) | 0% | 14.7 | 1,294 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 15,289 | 15,289 | - | - | Restricted Stock Units FY22 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2021 | 2,978 | 11,875 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2021 | 2,978 | 19,362 | - | - | Restricted Stock Units FY21 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.74 per share. | 23 Jun 2021 | 858 | 11,017 (0%) | 0% | 13.7 | 11,789 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2021 | 1,164 | 9,233 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2021 | 1,164 | 9,314 | - | - | Restricted Stock Units | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.60 per share. | 21 Jun 2021 | 336 | 8,897 (0%) | 0% | 12.6 | 4,234 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 4,205 | 9,281 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 4,205 | 0 | - | - | Restricted Stock Units Retention Plan | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.18 per share. | 20 May 2021 | 1,212 | 8,069 (0%) | 0% | 12.2 | 14,762 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 4,206 | 6,288 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 4,206 | 4,205 | - | - | Restricted Stock Units Retention Plan | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 20 Nov 2020 | 1,212 | 5,076 (0%) | 0% | 9.3 | 11,308 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2020 | 304 | 2,176 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2020 | 304 | 2,428 | - | - | Restricted Stock Units | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.32 per share. | 27 Jun 2020 | 94 | 2,082 (0%) | 0% | 9.3 | 876 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2020 | 22,340 | 22,340 | - | - | Restricted Stock Units FY21 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2020 | 406 | 1,998 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2020 | 406 | 0 | - | - | Restricted Stock Units FY18 | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.67 per share. | 21 Jun 2020 | 126 | 1,872 (0%) | 0% | 9.7 | 1,218 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jun 2020 | 1,164 | 1,951 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jun 2020 | 1,164 | 10,478 | - | - | Restricted Stock Units | |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.67 per share. | 19 Jun 2020 | 359 | 1,592 (0%) | 0% | 9.7 | 3,472 | Common Stock |
| Kewaunee Scientific Corpor... | Thomas D. Hull | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 8,411 | 8,411 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges